Nanocapsules Market Analysis By Application (Healthcare, Food & Nutraceuticals, Cosmetics, Agricultural Production, Others); By Therapy Area (Oncology, Pain Management, Endocrinology, Others), And Segment Forecasts, 2014-2025
出 版 商：Grand View Research
出版日期：2017/01/13
頁 數：90頁
文件格式：PDF
價 格：
USD 4,950 (Single-User License)
USD 7,950 (Multi-User License)
USD 9,950 (Global-User License)
USD 7,950 (Multi-User License)
USD 9,950 (Global-User License)
The global nanocapsules market is expected to reach a value of USD 4.0 billion by 2025, according to a new report by Grand View Research, Inc. Nanocapsules deliver bio active molecules by targeted delivery and is finds application in various industries such as healthcare, genetic engineering, food science and agriculture, cosmetics, agrochemicals, cleansing products, among others. The wide usage of these products across several industries promises lucrative opportunities for the development and commercialization of novel and improved therapies and solutions.
Nanocapsules’ life science applications rely on the ability to achieve controlled and effective release of nano-sized drug carriers to targeted zones. Nanocapsules in the field of healthcare are gaining popularity for its efficient drug targeting. It offers dispersion stability and the quick physiological response and the pyrophoric and oxidation properties are responsible for increased acceptance as an effective agent to diagnose and cure medical disorders. The application of nanotechnology in medicine has been realized to contain important therapeutic benefits, especially in oncology, resulting in the emergence of nano-oncology, a new field involving the chemotherapeutic or diagnostic properties of nanocapsules.
The use of nanotechnology has stretched across various streams of science and has found applications in the field of cosmetics and agriculture. Cosmetic products utilize polymeric nanoparticles (nanospheres and nanocapsules) for efficient topical administration. On the other hand, nanotechnology is recognized to be one of the most important tools in modern agriculture, and is anticipated to become a driving factor for strong economic growth in the near future. However, despite the numerous potential advantages of nanotechnology, agricultural applications are scarce in the current scenario and yet to achieve significant market potential. However, recent studies have demonstrated a positive preference for nanocapsules and their respective products and the increasing commercialization of nanotech products with clear benefits will likely drive consumer acceptance of more sensitive applications.
Further key findings from the study suggest:
Nanocapsules in oncology are engineered to target tumor sites followed by discharge of contents upon change in conditions.
Rapid development in the fields of pain management and endocrinology with respect to nanocapsule drug delivery is in pipeline and has high probability of commercialization.
North America and Europe accounted for a collective market share of 60%. this is attributed by the contribution of highly developed countries in increasing R&D and investing activities focusing on development of novel and highly effective improved therapies involving the use of nanocapsule.
Some of the major key players in the market include BioDelivery Sciences, Camurus, CARLINA Technologies, Cerulean Pharma Inc., NanoNutra, NanoSaar AG, ThioMatrix and L’Oreal.
Nanocapsules’ life science applications rely on the ability to achieve controlled and effective release of nano-sized drug carriers to targeted zones. Nanocapsules in the field of healthcare are gaining popularity for its efficient drug targeting. It offers dispersion stability and the quick physiological response and the pyrophoric and oxidation properties are responsible for increased acceptance as an effective agent to diagnose and cure medical disorders. The application of nanotechnology in medicine has been realized to contain important therapeutic benefits, especially in oncology, resulting in the emergence of nano-oncology, a new field involving the chemotherapeutic or diagnostic properties of nanocapsules.
The use of nanotechnology has stretched across various streams of science and has found applications in the field of cosmetics and agriculture. Cosmetic products utilize polymeric nanoparticles (nanospheres and nanocapsules) for efficient topical administration. On the other hand, nanotechnology is recognized to be one of the most important tools in modern agriculture, and is anticipated to become a driving factor for strong economic growth in the near future. However, despite the numerous potential advantages of nanotechnology, agricultural applications are scarce in the current scenario and yet to achieve significant market potential. However, recent studies have demonstrated a positive preference for nanocapsules and their respective products and the increasing commercialization of nanotech products with clear benefits will likely drive consumer acceptance of more sensitive applications.
Further key findings from the study suggest:
Nanocapsules in oncology are engineered to target tumor sites followed by discharge of contents upon change in conditions.
Rapid development in the fields of pain management and endocrinology with respect to nanocapsule drug delivery is in pipeline and has high probability of commercialization.
North America and Europe accounted for a collective market share of 60%. this is attributed by the contribution of highly developed countries in increasing R&D and investing activities focusing on development of novel and highly effective improved therapies involving the use of nanocapsule.
Some of the major key players in the market include BioDelivery Sciences, Camurus, CARLINA Technologies, Cerulean Pharma Inc., NanoNutra, NanoSaar AG, ThioMatrix and L’Oreal.
Table of Contents
Chapter 1. Methodology and Scope
1.1. Information procurement
1.2. Data Analysis
Chapter 2. Executive Summary
2.1. Nanocapsules Market - Industry Summary and Key Buying Criteria, 2014 - 2025
Chapter 3. Nanocapsules Market Variables, Trends & Scope
3.1. Market segmentation & scopes
3.2. Radiation Dose Monitoring: Market dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Penetration & growth prospect mapping
3.4. Nanocapsules - SWOT Analysis, By Factor (political & legal, economic and technological)
3.5. Industry Analysis -Porter’s
3.6. Nanocapsules Market: Company Market Share Analysis, 2015
Chapter 4. Nanocapsules Market: Application Estimates & Trend Analysis
4.1. Nanocapsules market: Application movement analysis
4.1.1. Healthcare
4.1.1.1. Healthcare market, 2014 - 2025 (USD Million)
4.1.2. Food & Nutraceuticals
4.1.2.1. Food & Nutraceuticals market, 2014 - 2025 (USD Million)
4.1.3. Cosmetics
4.1.3.1. Cosmetics market, 2014 - 2025 (USD Million)
4.1.4. Agricultural production
4.1.4.1. Agricultural production market, 2014 - 2025 (USD Million)
4.1.5. Others
4.1.5.1. Others market, 2014 - 2025 (USD Million)
Chapter 5. Nanocapsules Market: Therapy Area Estimates & Trend Analysis
5.1. Nanocapsules market: Therapy area movement analysis
5.2. Oncology
5.2.1. Oncology market, 2014 - 2025 (USD Million)
5.3. Pain Management
5.3.1. Pain Management market, 2014 - 2025 (USD Million)
5.4. Endocrinology
5.4.1. Endocrinology market, 2014 - 2025 (USD Million)
5.5. Others
5.5.1. Others market, 2014 - 2025 (USD Million)
Chapter 6. Nanocapsules Market: Regional Estimates & Trend Analysis, by Application And Therapy Area
6.1. Nanocapsules Market Share (%) Analysis, by Region, 2016 &2025
6.2. North America
6.2.1. U.S.
6.2.1.1. U.S. nanocapsules market, by application, 2014 - 2025 (USD Million)
6.2.1.2. U.S. nanocapsules market, by therapy area, 2014 - 2025 (USD Million)
6.2.2. Canada
6.2.2.1. Canada nanocapsules market, by application, 2014 - 2025 (USD Million)
6.2.2.2. Canada nanocapsules market, by therapy area, 2014 - 2025 (USD Million)
6.3. Europe
6.3.1. Germany
6.3.1.1. Germany nanocapsules market, by application, 2014 - 2025 (USD Million)
6.3.1.2. Germany nanocapsules market, by therapy area, 2014 - 2025 (USD Million)
6.3.2. U.K.
6.3.2.1. U.K. nanocapsules market, by application, 2014 - 2025 (USD Million)
6.3.2.2. U.K. nanocapsules market, by therapy area, 2014 - 2025 (USD Million)
6.4. Asia-Pacific
6.4.1. China
6.4.1.1. China nanocapsules market, by application, 2014 - 2025 (USD Million)
6.4.1.2. China nanocapsules market, by therapy area, 2014 - 2025 (USD Million)
6.4.2. India
6.4.2.1. India nanocapsules market, by application, 2014 - 2025 (USD Million)
6.4.2.2. India nanocapsules market, by therapy area, 2014 - 2025 (USD Million)
6.5. Latin America
6.5.1. Brazil
6.5.1.1. Brazil nanocapsules market, by application, 2014 - 2025 (USD Million)
6.5.1.2. Brazil nanocapsules market, by therapy area, 2014 - 2025 (USD Million)
6.5.2. Mexico
6.5.2.1. Mexico nanocapsules market, by application, 2014 - 2025 (USD Million)
6.5.2.2. Mexico nanocapsules market, by therapy area, 2014 - 2025 (USD Million)
6.6. MEA
6.6.1. South Africa
6.6.1.1. South Africa nanocapsules market, by application, 2014 - 2025 (USD Million)
6.6.1.2. South Africa nanocapsules market, by therapy area, 2014 - 2025 (USD Million)
6.6.2. Saudi Arabia
6.6.2.1. Saudi Arabia nanocapsules market, by application, 2014 - 2025 (USD Million)
6.6.2.2. Saudi Arabia Nanocapsules market, by therapy area, 2014 - 2025 (USD Million)
Chapter 7. Competitive Landscape
7.1. Company Profiles
7.1.1. BioDelivery Sciences
7.1.1.1. Company Overview
7.1.1.2. Financial Performance
7.1.1.3. Therapy area Benchmarking
7.1.1.4. Strategic Initiatives
7.1.2. Camurus
7.1.2.1. Company Overview
7.1.2.2. Financial Performance
7.1.2.3. Therapy area Benchmarking
7.1.2.4. Strategic Initiatives
7.1.3. Carlina Technologies
7.1.3.1. Company Overview
7.1.3.2. Financial Performance
7.1.3.3. Therapy area Benchmarking
7.1.3.4. Strategic Initiatives
7.1.4. Cerulean Pharma Inc.
7.1.4.1. Company Overview
7.1.4.2. Financial Performance
7.1.4.3. Therapy area Benchmarking
7.1.4.4. Strategic Initiatives
7.1.5. Nano Green Sciences, Inc.
7.1.5.1. Company Overview
7.1.5.2. Financial Performance
7.1.5.3. Therapy area Benchmarking
7.1.5.4. Strategic Initiatives
7.1.6. NanoNutra
7.1.6.1. Company Overview
7.1.6.2. Financial Performance
7.1.6.3. Therapy area Benchmarking
7.1.6.4. Strategic Initiatives
7.1.7. NanoSphere Health Science
7.1.7.1. Company Overview
7.1.7.2. Financial Performance
7.1.7.3. Therapy area Benchmarking
7.1.7.4. Strategic Initiatives
7.1.8. Eos Biosciences, Inc.
7.1.8.1. Company Overview
7.1.8.2. Financial Performance
7.1.8.3. Therapy area Benchmarking
7.1.8.4. Strategic Initiatives
7.1.9. L’Oreal
7.1.9.1. Company Overview
7.1.9.2. Financial Performance
7.1.9.3. Therapy area Benchmarking
7.1.9.4. Strategic Initiatives
7.1.10. GAT Food Essentials
7.1.10.1. Company Overview
7.1.10.2. Financial Performance
7.1.10.3. Therapy area Benchmarking
7.1.10.4. Strategic Initiatives
Chapter 1. Methodology and Scope
1.1. Information procurement
1.2. Data Analysis
Chapter 2. Executive Summary
2.1. Nanocapsules Market - Industry Summary and Key Buying Criteria, 2014 - 2025
Chapter 3. Nanocapsules Market Variables, Trends & Scope
3.1. Market segmentation & scopes
3.2. Radiation Dose Monitoring: Market dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Penetration & growth prospect mapping
3.4. Nanocapsules - SWOT Analysis, By Factor (political & legal, economic and technological)
3.5. Industry Analysis -Porter’s
3.6. Nanocapsules Market: Company Market Share Analysis, 2015
Chapter 4. Nanocapsules Market: Application Estimates & Trend Analysis
4.1. Nanocapsules market: Application movement analysis
4.1.1. Healthcare
4.1.1.1. Healthcare market, 2014 - 2025 (USD Million)
4.1.2. Food & Nutraceuticals
4.1.2.1. Food & Nutraceuticals market, 2014 - 2025 (USD Million)
4.1.3. Cosmetics
4.1.3.1. Cosmetics market, 2014 - 2025 (USD Million)
4.1.4. Agricultural production
4.1.4.1. Agricultural production market, 2014 - 2025 (USD Million)
4.1.5. Others
4.1.5.1. Others market, 2014 - 2025 (USD Million)
Chapter 5. Nanocapsules Market: Therapy Area Estimates & Trend Analysis
5.1. Nanocapsules market: Therapy area movement analysis
5.2. Oncology
5.2.1. Oncology market, 2014 - 2025 (USD Million)
5.3. Pain Management
5.3.1. Pain Management market, 2014 - 2025 (USD Million)
5.4. Endocrinology
5.4.1. Endocrinology market, 2014 - 2025 (USD Million)
5.5. Others
5.5.1. Others market, 2014 - 2025 (USD Million)
Chapter 6. Nanocapsules Market: Regional Estimates & Trend Analysis, by Application And Therapy Area
6.1. Nanocapsules Market Share (%) Analysis, by Region, 2016 &2025
6.2. North America
6.2.1. U.S.
6.2.1.1. U.S. nanocapsules market, by application, 2014 - 2025 (USD Million)
6.2.1.2. U.S. nanocapsules market, by therapy area, 2014 - 2025 (USD Million)
6.2.2. Canada
6.2.2.1. Canada nanocapsules market, by application, 2014 - 2025 (USD Million)
6.2.2.2. Canada nanocapsules market, by therapy area, 2014 - 2025 (USD Million)
6.3. Europe
6.3.1. Germany
6.3.1.1. Germany nanocapsules market, by application, 2014 - 2025 (USD Million)
6.3.1.2. Germany nanocapsules market, by therapy area, 2014 - 2025 (USD Million)
6.3.2. U.K.
6.3.2.1. U.K. nanocapsules market, by application, 2014 - 2025 (USD Million)
6.3.2.2. U.K. nanocapsules market, by therapy area, 2014 - 2025 (USD Million)
6.4. Asia-Pacific
6.4.1. China
6.4.1.1. China nanocapsules market, by application, 2014 - 2025 (USD Million)
6.4.1.2. China nanocapsules market, by therapy area, 2014 - 2025 (USD Million)
6.4.2. India
6.4.2.1. India nanocapsules market, by application, 2014 - 2025 (USD Million)
6.4.2.2. India nanocapsules market, by therapy area, 2014 - 2025 (USD Million)
6.5. Latin America
6.5.1. Brazil
6.5.1.1. Brazil nanocapsules market, by application, 2014 - 2025 (USD Million)
6.5.1.2. Brazil nanocapsules market, by therapy area, 2014 - 2025 (USD Million)
6.5.2. Mexico
6.5.2.1. Mexico nanocapsules market, by application, 2014 - 2025 (USD Million)
6.5.2.2. Mexico nanocapsules market, by therapy area, 2014 - 2025 (USD Million)
6.6. MEA
6.6.1. South Africa
6.6.1.1. South Africa nanocapsules market, by application, 2014 - 2025 (USD Million)
6.6.1.2. South Africa nanocapsules market, by therapy area, 2014 - 2025 (USD Million)
6.6.2. Saudi Arabia
6.6.2.1. Saudi Arabia nanocapsules market, by application, 2014 - 2025 (USD Million)
6.6.2.2. Saudi Arabia Nanocapsules market, by therapy area, 2014 - 2025 (USD Million)
Chapter 7. Competitive Landscape
7.1. Company Profiles
7.1.1. BioDelivery Sciences
7.1.1.1. Company Overview
7.1.1.2. Financial Performance
7.1.1.3. Therapy area Benchmarking
7.1.1.4. Strategic Initiatives
7.1.2. Camurus
7.1.2.1. Company Overview
7.1.2.2. Financial Performance
7.1.2.3. Therapy area Benchmarking
7.1.2.4. Strategic Initiatives
7.1.3. Carlina Technologies
7.1.3.1. Company Overview
7.1.3.2. Financial Performance
7.1.3.3. Therapy area Benchmarking
7.1.3.4. Strategic Initiatives
7.1.4. Cerulean Pharma Inc.
7.1.4.1. Company Overview
7.1.4.2. Financial Performance
7.1.4.3. Therapy area Benchmarking
7.1.4.4. Strategic Initiatives
7.1.5. Nano Green Sciences, Inc.
7.1.5.1. Company Overview
7.1.5.2. Financial Performance
7.1.5.3. Therapy area Benchmarking
7.1.5.4. Strategic Initiatives
7.1.6. NanoNutra
7.1.6.1. Company Overview
7.1.6.2. Financial Performance
7.1.6.3. Therapy area Benchmarking
7.1.6.4. Strategic Initiatives
7.1.7. NanoSphere Health Science
7.1.7.1. Company Overview
7.1.7.2. Financial Performance
7.1.7.3. Therapy area Benchmarking
7.1.7.4. Strategic Initiatives
7.1.8. Eos Biosciences, Inc.
7.1.8.1. Company Overview
7.1.8.2. Financial Performance
7.1.8.3. Therapy area Benchmarking
7.1.8.4. Strategic Initiatives
7.1.9. L’Oreal
7.1.9.1. Company Overview
7.1.9.2. Financial Performance
7.1.9.3. Therapy area Benchmarking
7.1.9.4. Strategic Initiatives
7.1.10. GAT Food Essentials
7.1.10.1. Company Overview
7.1.10.2. Financial Performance
7.1.10.3. Therapy area Benchmarking
7.1.10.4. Strategic Initiatives
